Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001478835-13-000001
Filing Date
2013-06-26
Accepted
2013-06-26 16:00:52
Documents
1
Period of Report
2013-06-24

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 4029
  Complete submission text file 0001478835-13-000001.txt   5550
Mailing Address 544 EGERTON ST LONDON A6 N5W 3Z8
Business Address 544 EGERTON ST LONDON A6 N5W 3Z8 519-434-1540
Tribute Pharmaceuticals Canada Inc. (Issuer) CIK: 0001159019 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 602-250 SYDENHAM ST LONDON A6 N6A5S1
Business Address
thrasher francis martin (Reporting) CIK: 0001478835 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-31198 | Film No.: 13934513